From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
IntegriChain’s specialty data solutions give bio/pharma manufacturers the insights they need to differentiate their products on the patient access experience.
IntegriChain’s Specialty Analytics delivers actionable, diagnostic insights that focus patient services and field account teams on the patients, providers, pharmacies, and payers where proactive interventions can have the biggest impact on initiation, adherence, and persistence. Our suite of diagnostic patient access analytics explain not just “what happened?”, but more importantly “why is it happening?” on key performance metrics like prior authorizations, cancellations, and forced transfers. With these insights, manufacturers can address the most important patient access challenge, and quickly alert brands to upcoming friction points in patient access and challenging patient cases.
IntegriChain Specialty Data Aggregation brings multiple datasets, including patient status data from specialty pharmacies, hub, co-pay, rebate claims, formulary data, and additional patient services information, into a single, unified analytics platform. Longitudinal patient records cover all interaction points on the therapy continuum. But we don’t stop there. Holistic patient journey insights must be built on “analytics ready” datasets. Our proprietary data science and AI processes actively seek out and resolve both explicit and implicit data issues, creating enriched patient access datasets to address inherent shortcomings in traditional specialty data. We create analytics-ready datasets that form the basis for justifiable, actionable insights.
Benchmarks based on trends across therapeutic categories provide targets for specialty brand performance against industry standards for specialty pharmacies, payers, and providers. We build dynamic benchmarks based on unique baskets of products that correspond to our customers’ definition of markets, not just therapeutic categories. These market benchmarks let specialty brands answer the question “what does good look like?” around all components of specialty patient access.
IntegriChain’s specialty data and analytics offering includes event-driven user notifications on key patient access milestones that give you the ability to anticipate potential risk-based outcomes and actionable solutions.
We score a script’s likely risk for access and shipment based on heuristic algorithms that monitor performance across the entire specialty data warehouse, and immediately notify critical reimbursement resources. Early and informed interventions on challenging access situations prevent script abandonment, and differentiate your product from the first patient interaction.
Please complete the form to provide us with some background information on your specialty product and data strategy